IF by specialty › Urology & Nephrology
Prostate Cancer and Prostatic Diseases — Impact Factor
The 2025 Impact Factor of Prostate Cancer and Prostatic Diseases is 5.6 (quartile not confirmed; subscription or hybrid).
- Impact Factor
- 5.6 JCR 2025
- JCR category
- Urology & Nephrology
- Quartile
- quartile not confirmed
- Publisher
- Nature Portfolio
- Open access
- subscription or hybrid
- IF source
- nature.com
Position within the field
Ranked 13 of the 41 journals in Urology & Nephrology on this site (top 50%).
Urology & Nephrology journals with a similar Impact Factor
- The Journal of Urology IF 6.8
- European Urology Focus IF 6.3
- Kidney International Reports IF 6.2
- Clinical Kidney Journal IF 5.3
- European Urology Open Science IF 4.3
- Kidney Medicine IF 4.1
About this value
The Journal Impact Factor of Prostate Cancer and Prostatic Diseases (JCR 2025, released June 2026) is 5.6. Values are compiled by cross-checking figures published by publishers and societies against public aggregators; this is not a reproduction of Clarivate Journal Citation Reports™. Confirm the current value on the publisher's page or in JCR before deciding where to submit. The quartile (Q1–Q4) is the journal's relative position within its JCR category; Q1 means the top 25%.
Last updated September 2026. Report errors via the contact form. Other journals in the same category: Urology & Nephrology.